by Steven R. Feldman, MD, PhD; Joel M. Gelfand, MD, MSCE; and Alice B. Gottlieb, MD, PhD
With increasing knowledge of the complexity of the immune system, more precisely targeted therapies have become available for the treatment of mode......READ MORE
by Steven R. Feldman, MD, PhD; Joel M. Gelfand, MD, MSCE; and Alice B. Gottlieb, MD, PhD
Individualized psoriasis care involves the consideration of disease severity and patient-level factors such as comorbidities, family history, and p......READ MORE
When there appears to be a loss of response to tumor necrosis factor inhibitor (TNFi) therapy, aside from ruling out adherence issues, consideratio......READ MORE
For more limited forms of psoriasis, there is a great need for topical therapies that can be used long-term. For more extensive disease, unmet need......READ MORE
Currently available biologics effectively treat patients with psoriasis within just a few months in the vast majority of cases. As such, the geneti......READ MORE
Some biologic therapies used in the treatment of plaque psoriasis have shown favorable effects on biomarkers of cardiovascular risk, such as C-reac......READ MORE
